Literature DB >> 12907390

Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection.

Michael R Weed1, Robert D Hienz, Joseph V Brady, Robert J Adams, Joseph L Mankowski, Janice E Clements, M Christine Zink.   

Abstract

Despite the high incidence of cognitive and motor impairment in acquired immunodeficiency syndrome (AIDS) patients, the mechanisms of AIDS-related central nervous system (CNS) pathology are not completely understood. Infection with simian immunodeficiency virus (SIV) in macaques provides an excellent model of AIDS, including human immunodeficiency virus (HIV)-induced CNS pathology and cognitive/behavioral impairment. Co-inoculation with two SIV strains, SIV/17E-Fr and SIV/DeltaB670, accelerates SIV CNS disease, producing SIV encephalitis in over 90% of pig-tailed macaques within 3 months. In the present study, this SIV model was employed to identify cellular and viral correlates of behavioral impairment following SIV infection. Measures of psychomotor speed (simple reaction time), fine motor control (bimanual motor task), and general motor activity (home cage movement) were all adversely affected by SIV disease. Prior to euthanasia, performance was significantly impaired in both a simple reaction time task in 6 of 12 monkeys and a bimanual motor task in 5 of 6 monkeys. All monkeys evaluated (11 of 11) showed significant reductions in spontaneous motor activity. Significant correlations were found between impaired performance on the bimanual motor test and axonal damage (accumulation of beta-amyloid precursor protein in the corpus callosum) as well as increased microglial activation and macrophage infiltration (levels of CD68 and Ham56 immunostaining). These results suggest that axonal damage is related to the behavioral impairment induced by infection with SIV. The axonal damage may result from neuroimmune responses, including microglial and macrophage activation. Therefore, axonal damage may be a morphologic manifestation of neuronal dysfunction that underlies development of behavioral impairment in HIV/SIV CNS infection.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2003        PMID: 12907390     DOI: 10.1080/13550280390218751

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  60 in total

Review 1.  Pathology of HIV-1 infection of the central nervous system. A review.

Authors:  L R Sharer
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

Review 2.  The simian immunodeficiency viruses.

Authors:  R C Desrosiers
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Prospects for therapy of HIV-associated neurologic diseases.

Authors:  N Sacktor; J McArthur
Journal:  J Neurovirol       Date:  1997-04       Impact factor: 2.643

4.  Motor analysis predicts progression in HIV-associated brain disease.

Authors:  G Arendt; H Hefter; F Hilperath; H J von Giesen; G Strohmeyer; H J Freund
Journal:  J Neurol Sci       Date:  1994-05       Impact factor: 3.181

5.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

6.  Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Authors:  F W Wit; R van Leeuwen; G J Weverling; S Jurriaans; K Nauta; R Steingrover; J Schuijtemaker; X Eyssen; D Fortuin; M Weeda; F de Wolf; P Reiss; S A Danner; J M Lange
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

7.  Clinical-neuropathologic correlation in HIV-associated dementia.

Authors:  J D Glass; S L Wesselingh; O A Selnes; J C McArthur
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

Review 8.  Simian immunodeficiency virus: a model for neuroAIDS.

Authors:  H S Fox; L H Gold; S J Henriksen; F E Bloom
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

Review 9.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  33 in total

1.  Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease.

Authors:  Kelly A Meulendyke; Ceereena Ubaida-Mohien; Julia L Drewes; Zhaohao Liao; Lucio Gama; Kenneth W Witwer; David R Graham; M Christine Zink
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

Review 2.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

3.  SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation.

Authors:  Michael Weed; Robert J Adams; Robert D Hienz; Kelly A Meulendyke; Michael E Linde; Janice E Clements; Joseph L Mankowski; M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-28       Impact factor: 4.147

Review 4.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

5.  Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.

Authors:  Paul L Soto; Kristin M Wilcox; Yun Zhou; Anil Kumar; Nancy A Ator; Mark A Riddle; Dean F Wong; Michael R Weed
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

6.  Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.

Authors:  Eleanor S Roberts; Salvador Huitron-Resendiz; Michael A Taffe; Maria Cecilia G Marcondes; Claudia T Flynn; Caroline M Lanigan; Jennifer A Hammond; Steven R Head; Steven J Henriksen; Howard S Fox
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

7.  Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS.

Authors:  Eva-Maria Ratai; Jeffrey P Bombardier; Chan-Gyu Joo; Lakshmanan Annamalai; Tricia H Burdo; Jennifer Campbell; Robert Fell; Reza Hakimelahi; Julian He; Patrick Autissier; Margaret R Lentz; Elkan F Halpern; Eliezer Masliah; Kenneth C Williams; Susan V Westmoreland; R Gilberto González
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

Review 8.  Behavioral and neurophysiological hallmarks of simian immunodeficiency virus infection in macaque monkeys.

Authors:  P D Cheney; M Riazi; J M Marcario
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

Review 9.  Virus-host interaction in the simian immunodeficiency virus-infected brain.

Authors:  Howard S Fox
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

10.  Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.

Authors:  Maria J Polyak; Pornpun Vivithanaporn; Ferdinand G Maingat; John G Walsh; William Branton; Eric A Cohen; Rick Meeker; Christopher Power
Journal:  FASEB J       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.